Today, the screeners at HealthTechMovers.com picked up 3 HealthTech Stocks up over 52% past 10 days and have been added to our watchlist. These are very volatile stocks so please do your own research before you make any investments. While we list the ratings of various 3rd party services, we're not recommending these stocks and we're not paid by the featured tickers, we simply report the big movers. If the editor has a position, it will be noted below the charts.
MarketInsidersPress.com is also looking into these tickers DAWN, COGT, RMD, BSX, RACE, RTX and more.
One resource you need to consider using Tipranks.com where as a premium member you get access to all buy ratings, price targets and insider trading signals. Click here for more on Tipranks.com.
Inozyme Pharma, INZY
Summary: Inozyme Pharma Inc. is a biopharmaceutical company. It engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue and skeleton diseases. The company's product candidate consist INZ-701, which is in clinical stage. Inozyme Pharma Inc. is based in Boston, Massachusetts.
Recent INZY Stock Price (approx 10:00am EST.): $5.45
Previous Close for INZY Stock: $4.69
Percentage Price Change Past 10 Days for INZY stock: +66%
TipRanks.com reports that Inozyme Pharma stock currently has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating for INZY stock with an average price target is $15.25.
Click here to get the full story on INZY stock >>
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Summary: BrainStorm Cell Therapeutics Inc. is a biotechnology company. It develops autologous stem cell therapies for highly debilitating neurodegenerative diseases such as Amyotrophic Lateral Sclerosis, Multiple Sclerosis and Parkinson's disease. Brainstorm Cell Therapeutics is based in New York.
Recent BCLI Stock Price (approx 10:00am EST.): $2.75
Previous Close for BCLI Stock: $2.5
Percentage Price Change Past 10 Days for BCLI stock: +60%
TipRanks.com reports that Brainstorm Cell Therapeutics stock currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating for BCLI stock with an average price target is $5.00.
Click here to get the full story on BCLI stock >>
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Summary: Aquestive Therapeutics, Inc. is a specialty pharmaceutical company. It commercializes medicines to solve critical health care problems as well as engages on late-stage proprietary product pipeline which focuses on the treatment of diseases of central nervous system. Aquestive Therapeutics, Inc. is based in NJ, United States.
Recent AQST Stock Price (approx 10:00am EST.): $1.20
Previous Close for AQST Stock: $1.15
Percentage Price Change Past 10 Days for AQST stock: +52%
TipRanks.com reports that Aquestive Therapeutics stock currently has 5 analysts offering 12-month price targets and the consensus is a Strong Buy rating for AQST stock with an average price target is $6.10.
Click here to get the full story on AQST stock >>
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Just a reminder, one resource you need to consider using Tipranks.com where as a premium member you get access to all buy ratings, price targets and insider trading signals. Click here for more on Tipranks.com.
The other great tool for charting is TradingView.com, so you might want to check that out too.
The information in this article was pulled from third part services. The prices listed above are not real-time and will be delayed at least 15 minutes.
MarketInsidersPress.com keeps investors informed of the top moving stocks within each sector including Health & Biotech, Technology, Energy, Metals & Mining, Financial, Consumer, Communication Services and more. We provide investors with timely information including insider trades news on top moving stocks. All information is sourced from our proprietary stocks screens, partner stock analysts and breaking news that identify and monitor stocks that are on the move. Join thousands of investors who already signed up for our free subscription to MarketInsidersPress.com.